I think the question is absolutely legitimate. However, as I said, CSIS is not in the business of running the lab. That is why we went to them with our concerns about national security in 2018 and to share with them our expertise. This is our job. We share with them our expertise. Then they reacted by telling us about a number of issues.
I believe PHAC has testified, as the documents that have been shared with the committee demonstrate, about how those vials of ingredients were transported. There are international rules for this. The problem is the authorization. My understanding—and again, PHAC should speak to those details—is that it was not a security issue with those vials. It was an authorization issue, which speaks more to the potential espionage concerns.